Search | Browse by Day | Author Index

Author Index: B

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Bae, J.
  • CURRENT STATUS AND SOCIETAL CONSENSUS REGARDING END-OF-LIFE TREATMENT DECISIONS IN KOREA
    • Bailey, M. D.
  • ELICITING PATIENTS' REVEALED PREFERENCES: AN INVERSE MARKOV DECISION PROCESS APPROACH
    • Baker, G. R.
  • DIAGNOSTIC ERRORS ARE COMMON CAUSES OF ADVERSE EVENTS IN HOSPITALIZED CANADIAN CHILDREN
    • Baker, L.
  • ATTITUDES OF EMERGENCY NURSES TOWARD THE DELIVERY OF SMOKING CESSATION COUNSELING
    • Balasubramanian, H.
  • MEASURING THE BENEFIT OF PSA SCREENING FROM THE PATIENT AND SOCIETAL PERSPECTIVES
    • Bansback, N.
  • COST-EFFECTIVENESS OF NOVEL ANTIRETROVIRALS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
  • THE COST-EFFECTIVENESS OF HEROIN ASSISTED TREATMENT FOR CHRONIC, TREATMENT-REFRACTORY OPIOID ADDICTS
  • USING A DISCRETE CHOICE EXPERIMENT TO ESTIMATE HEALTH STATE UTILITY VALUES
    • Barnes, J.
  • EVALUATING AN H1N1 DECISION AID FOR FAMILIES
    • Barnett, P. G.
  • COST-EFFECTIVENESS OF NOVEL ANTIRETROVIRALS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
    • Barratt, A.
  • THREE SIMPLE QUESTIONS TO IMPLEMENT EVIDENCE-BASED PRACTICE AND INCREASE PATIENT INVOLVEMENT
    • Barrett, B.
  • COST-EFFECTIVENESS ANALYSIS OF A RANDOMIZED TRIAL COMPARING CARE MODELS FOR CHRONIC KIDNEY DISEASE
    • Barrett, M. L.
  • MISSED DIAGNOSES OF ACUTE MYOCARDIAL INFARCTION IN THE EMERGENCY DEPARTMENT: AN EXPLORATION USING HCUP DATA
    • Barron, Y.
  • REVIEW OF PRESCRIPTION MODIFICATIONS: A NOVEL STRATEGY TO ASSESS PHYSICIAN RESPONSE TO MEDICATION ALERTS
    • Barry, M. J.
  • A COST-EFFECTIVENESS ANALYSIS OF THERAPEUTIC OPTIONS FOR LOW RISK PROSTATE CANCER
    • Barsoum, W. K.
  • DEVELOPING A VALID METHOD OF PREDICTING RETURNING TO WORK FOLLOWING PRIMARY TOTAL KNEE ARTHROPLASTY
    • Basu, A.
  • PLENARY PRESENTATION OF TOP-RANKED ABSTRACTS
    • Basu, R.
  • COMPARATIVE EFFECTIVENESS RESEARCH: ERECTILE DYSFUNCTION LONGITUDINAL OUTCOMES AND COSTS ACROSS TREATMENTS FOR PROSTATE CANCER
    • Batty, A. J.
  • A RATIONAL APPROACH FOR DETERMINING THE APPROPRIATE NUMBER OF MONTE CARLO SIMULATIONS REQUIRED IN HEALTH ECONOMIC ANALYSES
    • Batun, S.
  • OPTIMAL LIVER ACCEPTANCE POLICIES FOR RISK-SENSITIVE PATIENTS
    • Bauch, C. T.
  • IS A MASS IMMUNIZATION PROGRAM FOR PANDEMIC (H1N1) 2009 GOOD VALUE FOR MONEY? EVIDENCE FROM THE CANADIAN EXPERIENCE
    • Bauer, C. Y. S.
  • CHANGES IN STRUCTURE OF DIAGNOSIS KNOWLEDGE DUE TO A CHEST PAIN DIAGNOSIS TUTORIAL
    • Bavinger, J. C.
  • IS THERE A DIFFERENCE BETWEEN ORGANIC AND CONVENTIONAL ANIMAL PRODUCTS? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
  • IS THERE A DIFFERENCE BETWEEN ORGANICALLY AND CONVENTIONALLY GROWN PRODUCE? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
    • Bayoumi, A. M.
  • THE EFFECTS OF USING DIFFERENT PRIOR DISTRIBUTIONS FOR BETWEEN-STUDY VARIANCE ON OUTCOMES IN BAYESIAN RANDOM-EFFECTS META-ANALYSIS
  • COMPARISON OF THREE INDIRECT MEASURES OF HEALTH UTILITIES IN HIV
  • MODEL TO PREDICT HEALTH UTILITY SCORES FROM CD4 COUNT IN HIV
  • COST-EFFECTIVENESS OF NOVEL ANTIRETROVIRALS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
  • SMDM KEYNOTE PRESENTATION
    • Beca, J.
  • ECONOMIC EVALUATION OF GENETIC TEST IN COMBINATION WITH PREVENTIVE DONEPEZIL TREATMENT FOR AMNESTIC MILD COGNITIVE IMPAIRMENT (AMCI) PATIENTS
  • SHOULD HEPATITIS B SCREENING BE ADDED TO THE UNITED STATES IMMIGRATION MEDICAL EXAM? A COST-UTILITY ANALYSIS
    • Bechtold, T.
  • BREASTHEALTHDECISIONS.ORG: RISK ASSESSMENT AND DECISION SUPPORT FOR BREAST CANCER PREVENTION
    • Beck, C. E.
  • DECISION MAKING IN THE MANAGEMENT OF CHILDREN HOSPITALIZED WITH ACUTE IMMUNE THROMBOCYTOPENIC PURPURA: UNDERSTANDING CHILD, PARENT, AND HEALTH CARE PROFESSIONAL PERSPECTIVES
  • EXPLORING THE EXPERIENCE OF ACUTE IMMUNE THROMBOCYTOPENIC PURPURA THROUGH NARRATIVES OF CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA, THEIR PARENTS, AND HEALTH CARE PROFESSIONALS
    • Beck, E. J.
  • DECISION MAKING FOR HIV PREVENTION AND TREATMENT SCALE UP: BRIDGING THE GAP BETWEEN THEORY AND PRACTICE
    • Beck, M.
  • THE EFFECT OF A PHYSICIAN-ENHANCED CLINICAL DECISION SUPPORT TOOL FOR GUIDING VENOUS THROMBOEMBOLISM PHARMACOPROPHYLAXIS IN LOW-RISK PATIENTS
    • Begen, M. A.
  • REDUCING PATIENT WAIT TIMES FOR RADIATION THERAPY AND IMPROVING THE RADIATION TREATMENT PLANNING EFFICIENCY WITH THE AID OF A DISCRETE-EVENT SIMULATION MODEL
    • Belanger, D.
  • USING MIXED TREATMENT COMPARISONS TO GENERATE RECOMMENDATIONS FOR OPTIMAL USE OF MEDICATIONS
    • Bell, G. I.
  • THE COST-EFFECTIVENESS OF GENETIC SCREENING IN NEONATAL DIABETES
    • Benenson, S.
  • POORLY PERCEIVED PERSONAL ACCOUNTABILITY: INFECTION CONTROL'S MISSING LINK?
    • Benhabib, H.
  • RESPIRATORY HOSPITALIZATIONS ASSOCIATED WITH PALIVIZUMAB COMPLIANCE IN THE CANADIAN REGISTRY OF SYNAGIS (CARESS)
    • Benish, W. A.
  • THE CHANNEL CAPACITY OF A BINARY DIAGNOSTIC TEST
    • Bentley, T. G.
  • THE IMPORTANCE OF PREVALENCE ON SETTING POSITIVE TEST THRESHOLDS AND ON TEST OUTCOMES: THE CASE OF TUBERCULOSIS
    • Berg, S.
  • IS THERE A NEED FOR A PATIENT DECISION AID FOR PRENATAL SCREENING?: PRENATAL PATIENTS' REPORTS ABOUT THEIR DECISION PROCESS
  • SHARED DECISION MAKING FOR WOMEN WITH BREAST CANCER: KNOWLEDGE, VALUES, AND DECISIONAL CONFLICT OVER TIME
    • Berger, S. E.
  • COMPARISON OF VARIANTS OF A COMPUTERIZED CHEST PAIN DIAGNOSIS TUTOR
    • Berlowitz, D. R.
  • EFFECTIVENESS OF ACUTE GERIATRIC UNITS: EXPLORING HETEROGENEITY OF TREATMENT EFFECT AMONG SENIORS HOSPITALIZED FOR PNEUMONIA
    • Betsch, T.
  • INTUITION IN DECISION MAKING - POTENTIAL AND SHORTCOMINGS
    • Beusterien, K. M.
  • DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISION FUNCTION QUESTIONNAIRE
    • Bhandari, A.
  • WHEN SHOULD END-STAGE LIVER DISEASE (ESLD) PATIENTS UPDATE THEIR MODEL FOR END-STAGE LIVER DISEASE (MELD) SCORE?
    • Bhattacharya, J.
  • U.S. CHILDHOOD OBESITY POLICIES AND THEIR PROJECTED IMPACT ON ADULT HEALTH THROUGH 2040
    • Bibbins-Domingo, K.
  • POTENTIAL IMPACT ON DIABETES AND CARDIOVASCULAR DISEASES FROM A ONE-PENNY-PER-OUNCE EXCISE TAX ON SUGAR-SWEETENED BEVERAGES
    • Biddle, A. K.
  • CONCURRENT ORAL SESSION K: METHODS IN HEALTH TECHNOLOGY ASSESSMENT
    • Bielecky, T.
  • REDUCING PATIENT WAIT TIMES FOR RADIATION THERAPY AND IMPROVING THE RADIATION TREATMENT PLANNING EFFICIENCY WITH THE AID OF A DISCRETE-EVENT SIMULATION MODEL
    • Bilir, S. P.
  • THE IMPORTANCE OF FRAILTY WHEN CONSIDERING ANDROGEN-DEPRIVATION THERAPY FOR LOW-RISK BIOCHEMICAL RECURRENCE OF PROSTATE CANCER: A DECISION ANALYSIS
    • Birkeland, K. I.
  • COST-EFFECTIVENESS OF INTENSIVE LIFESTYLE INTERVENTION IN PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES
    • Birken, C. S.
  • DECISION MAKING IN THE MANAGEMENT OF CHILDREN HOSPITALIZED WITH ACUTE IMMUNE THROMBOCYTOPENIC PURPURA: UNDERSTANDING CHILD, PARENT, AND HEALTH CARE PROFESSIONAL PERSPECTIVES
  • EXPLORING THE EXPERIENCE OF ACUTE IMMUNE THROMBOCYTOPENIC PURPURA THROUGH NARRATIVES OF CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA, THEIR PARENTS, AND HEALTH CARE PROFESSIONALS
    • Bischof, M.
  • THE ECONOMIC BURDEN OF ACUTE CARE HOSPITALIZATIONS FOR FRACTURES RELATED TO OSTEOPOROSIS IN CANADA
    • Bisoffi, Z.
  • WHY ARE CLINICIANS RELUCTANT TO APPLY THRESHOLD THEORY?
    • Black, C.
  • THE USE OF MAPPING IN ESTIMATES OF COST-EFFECTIVENESS: HELPFUL OR HARMFUL?
    • Black, R. S.
  • THE A6 CYCLE: A METHOD FOR IDENTIFYING EVIDENCE-BASED LABORATORY MEDICINE BEST PRACTICES AND A TECHNOLOGY ASSESSMENT VALIDATION
    • Black, S.
  • ECONOMIC EVALUATION OF GENETIC TEST IN COMBINATION WITH PREVENTIVE DONEPEZIL TREATMENT FOR AMNESTIC MILD COGNITIVE IMPAIRMENT (AMCI) PATIENTS
    • Blackhouse, G.
  • THE DIAGNOSTIC ACCURACY AND COST-EFFECTIVENESS OF SEROLOGIC TESTS IN THE DIAGNOSIS OF CELIAC DISEASE
  • THE APPLICATION OF POLICY DISEASE MODELS TO HEALTH CARE DECISION-MAKING IN DIABETES: FINDINGS FROM AN EVALUATION OF FOUR STRATEGIES FOR THE MANAGEMENT OF TYPE 2 DIABETES USING THE ONTARIO DIABETES ECONOMIC MODEL (ODEM)
    • Blakney, G.
  • POSTNATAL UMBILICAL CORD BLOOD TESTING: PROLIFERATION OF CONFOUNDING NON-VALUE ADDED LABORATORY TESTING
    • Blanchette, V. S.
  • DECISION MAKING IN THE MANAGEMENT OF CHILDREN HOSPITALIZED WITH ACUTE IMMUNE THROMBOCYTOPENIC PURPURA: UNDERSTANDING CHILD, PARENT, AND HEALTH CARE PROFESSIONAL PERSPECTIVES
  • EXPLORING THE EXPERIENCE OF ACUTE IMMUNE THROMBOCYTOPENIC PURPURA THROUGH NARRATIVES OF CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA, THEIR PARENTS, AND HEALTH CARE PROFESSIONALS
    • Blostein, M.
  • CLINICAL DECISION MAKING FOR PREVENTION OF STROKE FROM ATRIAL FIBRILLATION
    • Bloudek, L.
  • THE COMPARATIVE EFFECTIVENESS OF BIOMARKERS FOR ALZHEIMER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    • Boecker, A.
  • USING THE MEANS-END CHAIN APPROACH TO MAP CONSUMER DECISION MAKING: THE CASE OF NATURAL HEALTH PRODUCTS
    • Bohmer, E.
  • COMPOSITE CLINICAL ENDPOINTS: HANDLE WITH CARE?
    • Bojke, L.
  • GENERATING AND USING ELICITED EVIDENCE FOR DECISION MODELS
    • Bolge, S.
  • OBSERVED VERSUS RECOMMENDED PATIENT PRESCRIPTION REFILL BEHAVIOUR - ASSESSMENT OF ADALIMUMAB AND ETANERCEPT PRESCRIPTION GAPS FOR THE FIRST YEAR OF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    • Bond, W. F.
  • A QUALITATIVE REVIEW OF DIFFERENTIAL DIAGNOSIS GENERATORS
    • Bonner, L.
  • DO MEN SCHEDULING A PROSTATE BIOPSY BENEFIT FROM INFORMATION ABOUT POTENTIAL TREATMENT OPTIONS?
    • Boon, H.
  • USING THE MEANS-END CHAIN APPROACH TO MAP CONSUMER DECISION MAKING: THE CASE OF NATURAL HEALTH PRODUCTS
    • Boortz, S.
  • BREASTHEALTHDECISIONS.ORG: RISK ASSESSMENT AND DECISION SUPPORT FOR BREAST CANCER PREVENTION
    • Bornstein, M.
  • PHARMCOGENETIC TESTING AND EVIDENCE-BASED DECISION-MAKING IN ONTARIO: THE APPLICATION OF ONTARIO'S DECISION DETERMINANTS FRAMEWORK TO THE EVALUATION OF PHARMACOGENETIC TESTS
  • THE APPLICATION OF POLICY DISEASE MODELS TO HEALTH CARE DECISION-MAKING IN DIABETES: FINDINGS FROM AN EVALUATION OF FOUR STRATEGIES FOR THE MANAGEMENT OF TYPE 2 DIABETES USING THE ONTARIO DIABETES ECONOMIC MODEL (ODEM)
    • Bossuyt, P. M.
  • CORRECTING FOR PARTIAL VERIFICATION BIAS: A COMPARISON OF METHODS
    • Boutis, K.
  • COST-EFFECTIVENESS ANALYSIS OF CAST VERSUS SPLINT IN CHILDREN WITH ACCEPTABLY ANGULATED WRIST FRACTURES
    • Bowen, J. M.
  • REDUCING EMERGENCY DEPARTMENT WAIT TIMES: INSIGHTS FROM MATHEMATICAL MODELING
    • Bowling, M.
  • INVERSE PREFERENCE ELICITATION FOR DYNAMIC TREATMENT REGIMES
    • Boydell, K.
  • DECISION MAKING IN THE MANAGEMENT OF CHILDREN HOSPITALIZED WITH ACUTE IMMUNE THROMBOCYTOPENIC PURPURA: UNDERSTANDING CHILD, PARENT, AND HEALTH CARE PROFESSIONAL PERSPECTIVES
  • EXPLORING THE EXPERIENCE OF ACUTE IMMUNE THROMBOCYTOPENIC PURPURA THROUGH NARRATIVES OF CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA, THEIR PARENTS, AND HEALTH CARE PROFESSIONALS
    • Brackett, C.
  • DO TESTIMONIALS IN A COLON CANCER SCREENING DECISION AID INFLUENCE PATIENT DECISION MAKING?
    • Braddock, C.
  • MEDIATED DECISION SUPPORT IN PROSTATE CANCER SCREENING
    • Bradley, N.
  • THE APPLICATION OF POLICY DISEASE MODELS TO HEALTH CARE DECISION-MAKING IN DIABETES: FINDINGS FROM AN EVALUATION OF FOUR STRATEGIES FOR THE MANAGEMENT OF TYPE 2 DIABETES USING THE ONTARIO DIABETES ECONOMIC MODEL (ODEM)
    • Brady-Fryer, B.
  • DIAGNOSTIC ERRORS ARE COMMON CAUSES OF ADVERSE EVENTS IN HOSPITALIZED CANADIAN CHILDREN
    • Brailsford, S.
  • MODELING APPROACHES FOR ANALYSING HEALTH CARE PROBLEMS – AN INTRODUCTORY OVERVIEW AND COMPARISON
    • Braithwaite, R. S.
  • TOWARDS PREFERENCE-CONGRUENT CARE AT THE END OF LIFE: A MARKOV MODEL TO INFORM ADVANCE DIRECTIVE DECISIONS FOR PATIENT WITH COPD
  • CONCURRENT ORAL SESSION M: SIMULATION AND DECISION MODELING
    • Brandeau, M. L.
  • IS THERE A DIFFERENCE BETWEEN ORGANIC AND CONVENTIONAL ANIMAL PRODUCTS? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
  • COST EFFECTIVENESS OF SCREENING FOR ACUTE HIV AND HCV INFECTION IN INJECTION DRUG USERS
  • IS THERE A DIFFERENCE BETWEEN ORGANICALLY AND CONVENTIONALLY GROWN PRODUCE? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
  • DECISION MAKING FOR HIV PREVENTION AND TREATMENT SCALE UP: BRIDGING THE GAP BETWEEN THEORY AND PRACTICE
    • Bravata, D. M.
  • IS THERE A DIFFERENCE BETWEEN ORGANIC AND CONVENTIONAL ANIMAL PRODUCTS? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
  • IS THERE A DIFFERENCE BETWEEN ORGANICALLY AND CONVENTIONALLY GROWN PRODUCE? A SYSTEMATIC REVIEW OF THE HEALTH BENEFITS AND HARMS
    • Brazier, J.
  • USING A DISCRETE CHOICE EXPERIMENT TO ESTIMATE HEALTH STATE UTILITY VALUES
    • Breakey, V.
  • DECISION MAKING IN THE MANAGEMENT OF CHILDREN HOSPITALIZED WITH ACUTE IMMUNE THROMBOCYTOPENIC PURPURA: UNDERSTANDING CHILD, PARENT, AND HEALTH CARE PROFESSIONAL PERSPECTIVES
  • EXPLORING THE EXPERIENCE OF ACUTE IMMUNE THROMBOCYTOPENIC PURPURA THROUGH NARRATIVES OF CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA, THEIR PARENTS, AND HEALTH CARE PROFESSIONALS
    • Brehaut, J. C.
  • PARENTS OF CHILDREN WITH HEALTH PROBLEMS: HOW DOES THEIR HEALTH CHANGE OVER TIME?
  • CAN IPDAS CRITERIA BE USED TO ASSESS THE QUALITY OF INFORMED CONSENT DOCUMENTS?
  • CONCURRENT ORAL SESSION N: EVIDENCE FOR CLINICAL DECISIONS
    • Brenner, A.
  • RESIDENT PHYSICIANS PERSPECTIVES ON USE OF DECISION SUPPORT AND SHARED DECISION MAKING IN A CLINICAL SETTING
  • CONJOINT ANALYSIS VS. RATING AND RANKING FOR VALUES CLARIFICATION IN COLORECTAL CANCER SCREENING
    • Brezis, M.
  • POORLY PERCEIVED PERSONAL ACCOUNTABILITY: INFECTION CONTROL'S MISSING LINK?
  • HERD BEHAVIOR AND HERD IMMUNITY: DOES MAN HAVE PREEMINENCE ABOVE BEAST?
    • Bridges, J. F.
  • THE USE AND MISUSE OF ORTHOGONAL ARRAYS IN THE DESIGN OF CONJOINT ANALYSIS APPLICATIONS IN HEALTH
  • A COMPARISON OF RATING AND CONJOINT ANALYSIS METHODS TO MEASURE CONSUMER PREFERENCES FOR HEARING AID ATTRIBUTES
  • AN INTRODUCTION TO DISCRETE CHOICE EXPERIMENTS IN HEALTH CARE
  • PREFERENCES FOR THE BENEFITS AND RISKS OF NSAIDS AMONG OSTEOARTHRITIS PATIENTS IN THE UK
    • Brissette, S.
  • THE COST-EFFECTIVENESS OF HEROIN ASSISTED TREATMENT FOR CHRONIC, TREATMENT-REFRACTORY OPIOID ADDICTS
    • Broder, M. S.
  • A NOVEL USE OF NATURAL LANGUAGE PROCESSING TO ANALYZE MEDICAL DEVICE ADVERSE EVENT REPORTS
    • Bronstone, A.
  • TEN PERCENT OR GREATER WEIGHT LOSS IS A CLINICALLY MEANINGFUL OUTCOME IN THE TREATMENT OF OBESITY
    • Brooks, L. R.
  • THE PAST MAY DISAMBIGUATE THE PRESENT: PRIOR EXPERIENCE LEADS TO UNAMBIGUOUS INTERPRETATIONS OF AMBIGUOUS MEDICAL SYMPTOMS IN NOVICES
    • Brooks, W. B.
  • DO TESTIMONIALS IN A COLON CANCER SCREENING DECISION AID INFLUENCE PATIENT DECISION MAKING?
    • Brown, A. G.
  • ECONOMIC EVALUATION OF ANTIPLATELETS IN THE SECONDARY PREVENTION OF VASCULAR EVENTS IN STROKE PATIENTS
    • Brown, S. T.
  • COST-EFFECTIVENESS OF NOVEL ANTIRETROVIRALS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
    • Brundage, M.
  • THE IMPACT OF VALUES CLARIFICATION IN A DECISION AID: EVIDENCE FROM A RANDOMIZED CONTROLLED TRIAL EMERGES SLOWLY OVER TIME
    • Brunstein, A.
  • SIMULATION TRAINING AND DECISION SUPPORT FOR MEDICAL EDUCATION
    • Brunstein, J.
  • SIMULATION TRAINING AND DECISION SUPPORT FOR MEDICAL EDUCATION
    • Bruyninckx, R.
  • HOW MANY MORE PATIENTS WILL WE TREAT BY DECREASING THE THRESHOLD?
    • Bryan, S.
  • COMPREHENSIVE EVIDENCE SYNTHESIS AND TRIAL-BASED COST-EFFECTIVENESS ANALYSIS: CAN THEY BE COMFORTABLE BED FELLOWS?
    • Bryce, C. L.
  • THE ASSOCIATIONS OF MENOPAUSE AND HEALTH-RELATED QUALITY OF LIFE WITH HEALTH SERVICES UTILIZATION: RESULTS FROM THE STRIDE STUDY
    • Bryg, D. J.
  • NOT ALL LIPID LOWERING IS CREATED EQUAL: A META-ANALYSIS
    • Bryg, R. J.
  • NOT ALL LIPID LOWERING IS CREATED EQUAL: A META-ANALYSIS
    • Bui, A. T.
  • CLIENT FEEDBACK SURVEY: WHAT INFORMATION IS IMPORTANT TO ME TO LEARN ABOUT ANTIPSYCHOTIC MEDICATIONS?
  • ANTIPSYCHOTIC DECISION AID ACCEPTABILITY: FEEDBACK FROM CLIENTS, FAMILY MEMBERS, AND PHYSICIANS
    • Buntinx, F.
  • HOW MANY MORE PATIENTS WILL WE TREAT BY DECREASING THE THRESHOLD?
    • Burger, E.
  • HUMAN PAPILLOMAVIRUS TESTING FOR THE DETECTION OF CERVICAL INTRAEPITHELIAL NEOPLASIA: A SYSTEMATIC REVIEW
    • Burhans, D.
  • HOSPITAL LIBRARIES INFLUENCE PATIENT CARE: SURVEY RESULTS FROM 4 HOSPITALS
    • Burnside, E. S.
  • MUTUAL INFORMATION ANALYSIS USED TO DETERMINE MOST INFORMATIVE FEATURES IN BREAST CANCER DIAGNOSIS
  • DESIGNING RISK-TAILORED BREAST CANCER SCREENING POLICIES CONSIDERING IMPERFECT ADHERENCE
  • THE EFFECT OF BUDGETARY RESTRICTIONS ON THE OPTIMAL DECISION THRESHOLDS FOR BREAST CANCER DIAGNOSIS
    • Buthion, V. G.
  • MODELING PERFORMANCE OF IMAGING : A NEW PROPOSITION FOR PERFORMANCE APPRAISAL
    • Butow, P.
  • THREE SIMPLE QUESTIONS TO IMPLEMENT EVIDENCE-BASED PRACTICE AND INCREASE PATIENT INVOLVEMENT
    • Buttorff, C.
  • A COMPARISON OF RATING AND CONJOINT ANALYSIS METHODS TO MEASURE CONSUMER PREFERENCES FOR HEARING AID ATTRIBUTES
    • Butz, A. M.
  • PHARMACY LOCATION CORRELATION WITH FILLS OF INHALED CORTICOSTEROIDS IN URBAN CHILDREN WITH ASTHMA
    • Byrne, M. M.
  • ONCOLOGISTS' ATTITUDES AND BELIEFS ABOUT PATIENT PARTICIPATION IN CANCER CLINICAL TRIALS
  • DO RESEARCH PAYMENTS INCREASE PERCEIVED COERCION? INITIAL RESULTS OF A NOVEL FINANCIAL INCENTIVE COERCION ASSESSMENT INSTRUMENT
  • CONCURRENT ORAL SESSION L: METHODS AND APPLICATIONS IN COMPARATIVE EFFECTIVENESS RESEARCH
    • A B C D E F G H I J K L M N O P Q R S T U V W X Y Z